What is the current Price Target for the Mustang Bio, Inc. stock?

The average Mustang Bio, Inc. target price is $10.20. This is 729.27% higher than the current stock price. The highest price target is 753.66%, the lowest is 721.14%. 3 Analysts have issued a price target Mustang Bio, Inc. 2026 .

How high will the Mustang Bio, Inc. stock rise?

No reliable answer can be given as to how high the Mustang Bio, Inc. stock will rise. The performance of stocks, including the Mustang Bio, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Mustang Bio, Inc. stock today?

The performance of Mustang Bio, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Mustang Bio, Inc. stock fall?

The decline in Mustang Bio, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mustang Bio, Inc. Forecast, price target & analysts

$1.23

0.82% yesterday

Nasdaq, Nov 10, 10:00 pm CET

ISIN

US62818Q1040

Symbol

MBIO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Mustang Bio, Inc. Target price 2025 - Analyst rating & recommendation

Mustang Bio, Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Mustang Bio, Inc. Price Target

Target Price	$10.20
Price	$1.23
Potential	729.27% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Mustang Bio, Inc. 2026 . The average Mustang Bio, Inc. target price is $10.20. This is 729.27% register free of charge higher than the current stock price. The highest price target is $10.50 753.66% register free of charge , the lowest is $10.10 721.14% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Mustang Bio, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mustang Bio, Inc. stock has an average upside potential 2026 of 729.27% register free of charge . Most analysts recommend the Mustang Bio, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-26.24	-17.85
	91.32%	31.97%
P/E		negative

3 Analysts have issued a Mustang Bio, Inc. forecast for earnings per share. The average Mustang Bio, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-26.24	91.32%
2025	$-17.85 31.97% Unlock

Current	-1.52	92.50%
2025	-0.07 95.39% Unlock

Mustang Bio, Inc....

Discover more stocks with a high price target

Novo Nordisk 58.35%

TUI 56.79%

Adidas 52.97%

Deutsche Telekom 45.22%

Meta Platforms (Facebook) 41.27%

Adyen 38.23%

BYD 34.23%

BioNTech SE - ADR 32.51%

Coinbase Global, Inc. 29.61%

Infineon 28.48%

Microsoft 27.00%

Netflix 26.58%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now